Clara Ezed

Clara Ezed (Odularu) is a lawyer and pharmacist earning her post graduate law degrees from Nottingham law School and City Law School, London and her BSc in Pharmacy from the University of Strathclyde, Glasgow. She is a member of the Bar of England and Wales and a member of the General Pharmaceutical Council. She holds an MBA degree from the University of Middlesex.

Clara has spent 22 years in the healthcare industry spanning operational business development, R & D, commercial and regulatory compliance. She has held senior executive positions serving as an Executive and Non-Executive Board Director, Strategic Consultant to life science incubators, and Principal Consultant acting on behalf of Biotech, MedTech and pharma SMEs. 

Clara has successfully invested in a number of privately and publicly held companies including Alexion Pharmaceuticals (acquired by AstraZeneca), Emas Pharma (acquired by Bionical Group), Denfleet Pharmaceuticals (Acquired by Merz Pharma) and La Jolla Pharmaceutical.

Clara joined AXA Investment Managers Group (AXA IM Alts) in 2022 as a Director, within the Healthcare Private Equity investment management team.